[fusion_builder_container type=”flex” hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=””][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” center_content=”no” last=”true” min_height=”” hover_type=”none” link=”” border_sizes_top=”” border_sizes_bottom=”” border_sizes_left=”” border_sizes_right=”” first=”true”][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
In this essay, Holly Wood-Blake explores how the Misuse of Drugs Act 1971 came into being, how it was intended to work, and what disagreements over cannabis and MDMA can tell us about the relationship between evidence, politics, and harm.
For almost 55 years, the Misuse of Drugs Act 1971 (‘the Act’) has been the foundation of UK drug control policy. Yet, the world in which the Act operates has changed profoundly since 1971.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
Today’s drug market is more complex, fast-moving, and technologically connected than the one policymakers faced in the early 1970s. There are more substances in circulation – some of them cheaper, more potent or easier to obtain. Online communication and digital markets have changed how drugs are bought and sold. There is growing concern around the emergence of synthetic opioids in UK drug markets, following the devastating impact of the opioid crisis in North America. There is also far greater understanding today than in 1971 of drug dependence, prevention, treatment, and social factors linked to drug-related harm.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
A brief history of the Act
Between the 1920s and 1960s, British drug policy developed against a backdrop of growing international pressure for stricter control. While the UK’s ‘British System’ had allowed doctors to prescribe heroin and morphine to dependent patients under medical supervision, global attitudes were shifting towards prohibition.
Two international treaties were especially influential: the Single Convention on Narcotic Drugs (1961) and the Convention on Psychotropic Drugs (1971). These agreements encouraged participating states to restrict the production, possession, and supply of a wide range of substances through domestic law.
The conventions did not emerge in a vacuum. The 1961 Convention was heavily influenced by the United States, which had already begun pursuing prohibitionist drug policies at home.
For the UK, compliance required new primary legislation, resulting in the Misuse of Drugs Act 1971. The Act therefore reflects not only national concerns, but also a wider international turn towards criminalisation as the primary tool of drug control.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
How classification is intended to work
The Misuse of Drugs Act 1971 classifies controlled drugs into three categories: Class A, B, and C. The table below shows the classes, example substances, and associated criminal penalties as they stand in 2026.
[/fusion_text][fusion_table admin_label=”” fusion_table_type=”1″ fusion_table_rows=”” fusion_table_columns=”” awb-switch-editor-focus=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” render_logics=”” animation_type=”” animation_direction=”left” animation_color=”” hue=”” saturation=”” lightness=”” alpha=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
| Class | Example substances | Maximum penalty for possession | Maximum penalty for supply / intent to supply |
|---|---|---|---|
| A | Cocaine, heroin, MDMA | Seven years in prison, unlimited fine | Life in prison, unlimited fine |
| B | Cannabis, ketamine, mephedrone | Five years in prison, unlimited fine | 14 years in prison, unlimited fine |
| C | Benzodiazepines, gamma hydroxybutyrate (GHB) | Two years in prison, unlimited fine | 14 years in prison, unlimited fine |
[/fusion_table][fusion_separator style_type=”default” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” flex_grow=”0″ top_margin=”” bottom_margin=”” width=”” height=”20″ alignment=”center” border_size=”15″ weight=”” amount=”” sep_color=”#ffffff” hue=”” saturation=”” lightness=”” alpha=”” icon=”” icon_size=”” icon_color=”” icon_circle=”” icon_circle_color=”” /][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
A defining feature of the Act is its intended flexibility. When introducing the legislation, then Home Secretary James Callaghan said:
“The object here is to make, so far as possible, a more sensible differentiation between drugs. It will divide them according to their accepted dangers and harmfulness in the light of current knowledge and it will provide for changes to be made in classification in the light of new scientific knowledge.” – James Callaghan, Home Secretary, 1970
To support this, the Act established the Advisory Council on the Misuse of Drugs (ACMD), an independent expert body tasked with advising the government on drug harms and classification. The government can reclassify substances by statutory instrument following ACMD advice.
This mechanism reflects an important principle: if the state is to restrict individual freedom through criminal sanctions, it should do so based on robust evidence. In practice, however, scientific advice is only one factor in policymaking. Ministers may also consider public opinion, media attention, and wider political priorities.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
Evidence, politics, and public perception
Drug policy is emotive and often controversial. It intersects with criminal justice, public health, and morality, and as such tends to attract political and media scrutiny. As a result, decisions about classification are not always determined by scientific assessments of harm alone. Two high-profile examples from the 2000s, cannabis and MDMA, illustrate this tension.
Cannabis
Cannabis was reclassified from Class B to Class C in 2004, following recommendations from both the ACMD and The Police Foundation, an independent thinktank focused on policing and crime reduction. At the time, supporters of reclassification argued that criminal penalties for cannabis possession could themselves create harm, particularly through criminal records and unnecessary contact with the justice system.
“[The law around cannabis] inhibits accurate education about the relative risks of different drugs including the risks of cannabis itself. It gives large numbers of otherwise law-abiding people a criminal record. It inordinately penalises and marginalises young people for what might be little more than youthful experimentation…The evidence strongly indicates that the current law and its operation creates more harm than the drug itself.” The Police Foundation, 2000
However, in 2009 the government returned cannabis to Class B, despite ACMD advice that the harmfulness equates more closely with other Class C substances.
Then Home Secretary Jacqui Smith said the decision formed part of a wider effort to “tackle drugs and the harm they bring to families and communities”. When questioned by MPs about her decision not to follow ACMD advice, Smith argued that it was “perfectly reasonable to take into consideration evidence and views about police priorities and public perception.” Around the same time, Prime Minister Gordon Brown said, “If we are sending out a signal that we in any way find cannabis acceptable that is not the right thing to do.”
These statements suggested that classification was being used not only to reflect relative harm, but also as a tool of deterrence and public messaging.
MDMA
MDMA was banned and classified as Class A in 1977 and remains there to this day. In 2008, the ACMD recommended that MDMA be moved to Class B. The ACMD concluded that the harms associated with MDMA were not equivalent to those of some other Class A drugs, such as heroin or cocaine. It also noted that some harms linked to MDMA use were associated with ‘polydrug use’ (using more than one drug at once) and broader environmental factors, such as overheating in hot nightclubs. The ACMD also observed that MDMA’s original classification had been made when evidence about the drug’s toxicology and pharmacology was relatively limited, including early assumptions that it was a hallucinogenic.
“We believe that criminal justice measures will only have limited effect. It is of vital importance that issues of classification do not detract from messages concerning public health.” ACMD, 2009
The government did not accept the recommendation, and the debate intensified in 2009 when then Chair of the ACMD, Professor David Nutt, was removed from the role after publicly discussing the comparative risk of drug use and other potentially dangerous activities.
The decision prompted criticism from some academics and commentators, who argued that it raised important questions about the independence of scientific advice and how expert evidence is used in public policy.
More broadly, the episode focused attention on how governments should respond when expert recommendations differ from political priorities or public sentiment. From a public health perspective, some commentators argued that where official messaging is seen as insufficiently evidence-based, public trust may be weakened.
“You can have policies that go against your stated outcomes, for moral or political reasons: but that doesn’t mean you can hide the evidence, it simply means you must be clear that you don’t care about it.” Ben Goldacre, writer, broadcaster, and Professor of Evidence-Based Medicine, 2009
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
What these debates revealed
The cannabis and MDMA cases do not show that evidence is absent from policymaking. Rather, they illustrate that evidence operates alongside other pressures and priorities. To some extent, this is inevitable in democratic government, but it can create difficulties when the purpose of classification is unclear. If classification is intended to reflect pharmacological and social harm, it may produce one set of outcomes. If it is also expected to deter use, reassure the public, express moral disapproval, or respond to media concern, it may produce another.
When the purposes of drug classification become blurred, the system can lose coherence. This matters because classification shapes criminal penalties, policing priorities, public understanding of risk, and trust in official advice.
Drug regulation also affects communities unevenly. For example, people from minority ethnic backgrounds are consistently more likely to be stopped and searched than White people. In 2020/21, Black or Black British people made up 4% of the population but accounted for 17% of such searches. While the rate of finding prohibited items is similar across ethnic groups, Black people are more likely to be arrested following a stop and search, less likely to receive an out-of-court disposal, and therefore more likely to be prosecuted than White people.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
What next?
Nearly 55 years after its introduction, the Misuse of Drugs Act 1971 remains central to UK drug policy. But the evidence base, the drug market, and our understanding of harm have changed significantly. Revisiting the classification system would not necessarily mean abandoning it. It could instead mean asking clearer questions about what classification is for, what kinds of harm it should recognise, and whether it is achieving its stated aims.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
Holly Wood-Blake joined the SSA as a Science Communication Officer in January 2026, having previously worked in policy, public affairs, and research communication roles in the drug and alcohol treatment sector. Holly holds a Bachelor of Laws from the University of Bristol and a Master’s degree in Public Policy from the University of Bath. Her MSc dissertation, ‘This is your brain on discourse: A poststructuralist analysis of how ‘harm’ is conceptualised in the classification of controlled drugs under the Misuse of Drugs Act 1971’, explored how ideas of harm are constructed and applied within UK drug policy. She is particularly interested in how language, evidence, and problem framing shape policymaking, public understanding, and service design, especially in relation to addiction and multiple disadvantage.
[/fusion_text][fusion_text admin_label=”” awb-switch-editor-focus=”” columns=”” column_min_width=”” column_spacing=”” rule_style=”” rule_size=”” rule_color=”” hue=”” saturation=”” lightness=”” alpha=”” user_select=”” content_alignment_medium=”” content_alignment_small=”” content_alignment=”” disable_idd=”no” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” sticky_display=”normal,sticky” class=”” id=”” html_attributes=”W10=” width_medium=”” width_small=”” width=”” min_width_medium=”” min_width_small=”” min_width=”” max_width_medium=”” max_width_small=”” max_width=”” margin_top_medium=”” margin_right_medium=”” margin_bottom_medium=”” margin_left_medium=”” margin_top_small=”” margin_right_small=”” margin_bottom_small=”” margin_left_small=”” margin_top=”” margin_right=”” margin_bottom=”” margin_left=”” fusion_font_family_text_font=”” fusion_font_variant_text_font=”” font_size=”” line_height=”” letter_spacing=”” text_transform=”” text_color=”” render_logics=”” logics=”” animation_type=”” animation_direction=”left” animation_color=”” animation_speed=”0.3″ animation_delay=”0″ animation_offset=””]
The opinions expressed in this post reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]